• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract Vitamin K antagonists did not increase the risk of myelodysplastic syndrome in patients with non-valvular atrial fibrillation

byKathleen Lau
August 12, 2021
in StudyGraphics
0
Share on FacebookShare on Twitter

RELATED REPORTS

Extended aromatase inhibitor therapy reduces breast cancer recurrence in postmenopausal women

Schrödinger Halts CDC7 Inhibitor After Two Patient Deaths

Hydroxychloroquine may have a treatment role for chronic inflammatory cardiomyopathy

Tags: AFapixabanatrial fibrillationbloodblood cancercancercardiologydabigatrandirect oral anticoagulantsDOACdoacseliquishematologymyelodysplastic syndromeMyelodysplastic Syndromesnon-valvular atrial fibrillationoncologyPradaxarivaroxabanvitamin K antagonistVKAwarfarinxarelto
Previous Post

#VisualAbstract: Magnetic resonance imaging-targeted biopsy noninferior to standard biopsy for prostate cancer screening

Next Post

Wellness Check: Sleep

RelatedReports

Incidental findings common with breast imaging, often benign
Chronic Disease

Extended aromatase inhibitor therapy reduces breast cancer recurrence in postmenopausal women

August 21, 2025
Improved survival with bufulfan-cyclophosphamide combination vs total body irradiation
Pharma

Schrödinger Halts CDC7 Inhibitor After Two Patient Deaths

August 20, 2025
Colchicine may lower the risk of cardiovascular events in patients with coronary disease
Cardiology

Hydroxychloroquine may have a treatment role for chronic inflammatory cardiomyopathy

August 14, 2025
Radiation plus hormone therapy may improve prostate cancer survival
Chronic Disease

Talazoparib and enzalutamide improve survival in metastatic castration-resistant prostate cancer

August 14, 2025
Next Post
Plagiocephaly/brachycephaly associated with lower cognitive and academic achievement scores

Wellness Check: Sleep

Children’s hospital visits for suicide ideation and attempts are increasing

Global prevalence of depressive and anxiety symptoms in youth significantly increased during COVID-19

Standardized developmental screening of refugee children is recommended

Over one-million children estimated to have lost a caregiver due to the COVID-19 pandemic

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Extended aromatase inhibitor therapy reduces breast cancer recurrence in postmenopausal women
  • GSK and Hengrui Pharma Forge $500 Million China Collaboration
  • #VisualAbstract: Ciprofloxacin is Noninferior to Aminoglycoside–Ciprofloxacin for Treatment of Bubonic Plague
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.